CHART THE UNCHARTED
WE ARE TRANSFORMING LIFE SCIENCES INNOVATION BY CREATING AND INVESTING IN GLOBAL COMPANIES - STARTING IN JAPAN AND THE UNITED STATES
New Current
See all
September 12, 2023
Arialys Therapeutics Launches to Lead the Development of New Precision Medicines for Autoimmune Neuropsychiatric Diseases
Read MoreFeatured Creations
See all
Catalyzing Transpacific Partnership
The power of our transpacific partnerships lies at the heart of our investment and company building strategy. We leverage an extensive global network as well as an “on-the-ground”, local presence in both Japan and the United States. This enables us to access differentiated sourcing and early-stage investment opportunities for the creation and development of bespoke new biotech companies on both sides of the Pacific. Through this approach, the team gains insights and perspectives that enable it to maximize therapeutic impact for patients around the world, while generating attractive risk-adjusted returns for investors.
Catalys Pacific maximizes its profound global network and robust local presence in Japan to propel its mission of improving patient lives. It is an honor to be a part of that mission.”
Nobuo Hanai, PhD